Brain Computer Interface Training After Stroke

Sponsor
University of Aarhus (Other)
Overall Status
Recruiting
CT.gov ID
NCT04071587
Collaborator
Hammel Neurorehabilitation Centre and University Research Clinic (Other), Sygekassernes Helsefond (Other)
40
1
2
40.2
1

Study Details

Study Description

Brief Summary

In this study, we want to examine the effect of a new treatment approach for patients with severe upper limb paresis in the subacute phase after stroke. Brain Computer Interface (BCI) driven functional electrical stimulation will be compared to conventional training.

Condition or Disease Intervention/Treatment Phase
  • Device: Brain Computer Interface training
  • Behavioral: Control
N/A

Detailed Description

A randomized controlled pilot study will be conducted. Forty patients with severe UL paresis will be included. Patients with severe hemiparesis after stroke will be allocated to one of two treatment groups by a computerized randomization program. Patients in the intervention group will receive training with a BCI system paired with functional electrical stimulation and visual feedback (RecoveriX, gtec, Austria) as part of their rehabilitation. The targeted number of training sessions in the intervention group is 12. Patients in the control group will receive conventional upper limb training. All patients will receive other rehabilitation according to their needs.

Patients will be assessed by blinded raters before and after the intervention and 3 months post stroke. Main endpoint will be UL motor function assessed by Action Research Arm Test (ARAT) at 3 months post stroke. Other outcome measures comprise Fugl Meyer Motor Assessment and Functional Independence Measure. The patients and therapists' experience with this type of training will be evaluated with questionnaires and interviews.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients are randomized to one of two treatment options, intervention or standard rehabilitationPatients are randomized to one of two treatment options, intervention or standard rehabilitation
Masking:
Single (Outcomes Assessor)
Masking Description:
All assessments will be done by assessors blinded to treatment allocation.
Primary Purpose:
Treatment
Official Title:
Brain Computer Interface Training for Patients With Severe Upper Limb Paresis in the Subacute Phase After Stroke
Actual Study Start Date :
Aug 26, 2019
Anticipated Primary Completion Date :
Jul 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: BCI training

Patients randomized to this group will receive up to12 (minimum 8) sessions of BCI training with the RecoveriX system (gtec, Austria). The system combines EEG driven functional electrical stimulation with visual feedback. BCI training is provided as a part of standard training of the impaired upper limb.

Device: Brain Computer Interface training
Training with RecoveriX system.

Active Comparator: Control

Patients randomized to this control group will receive standard physiotherapy and occupational therapy for their impaired upper limb.

Behavioral: Control
Standard physiotherapy and occupational therapy according to clinical routines.

Outcome Measures

Primary Outcome Measures

  1. Action Research Arm Test (ARAT) [Upper limb function 90 days after stroke]

    Upper limb function on a scale of 0 - 57 (best)

Secondary Outcome Measures

  1. Fugl-Meyer Assessment (UL) [Upper limb impairment 90 days after stroke]

    Upper limb impairment on a scale from 0-66 (best)

  2. Functional Independence Measure [Functional independence 90 days after stroke]

    Independence in activities og daily living, 18-126 (best)

Other Outcome Measures

  1. Interviews [Through study completion, an average of 6 months]

    Qualitative assessment of user experiences

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • First ever or former stroke without UL motor residuals as confirmed by CT and / or MRI

  • 15 days to 60 days (+/- 3) after stroke onset

  • Severe paresis or paralysis defined as < 13 on Action Research arm Test (ARAT)

  • Able to give informed consent

  • Able to comply with treatment protocol.

Exclusion Criteria:
  • Other conditions limiting functional use of the affected UL,

  • Psychiatric / behavioral conditions that interfere with compliance to the protocol, epilepsy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hammel Neurorehabilitation Centre and University Research Clinic Hammel Aarhus Denmark 8450

Sponsors and Collaborators

  • University of Aarhus
  • Hammel Neurorehabilitation Centre and University Research Clinic
  • Sygekassernes Helsefond

Investigators

  • Principal Investigator: Iris Brunner, PhD, Aarhus University, Hammel Neurocenter

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT04071587
Other Study ID Numbers:
  • 649780
First Posted:
Aug 28, 2019
Last Update Posted:
Jan 10, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Aarhus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2022